[Therapy of prostato-vesiculitis].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002463:Cell Membrane Permeability; D002689:Chlamydia / Q000302:isolation & purification; D004917:Erythromycin / Q000627:therapeutic use; D005832:Genital Diseases, Male / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009174:Mycoplasma / Q000302:isolation & purification; D011472:Prostatitis / Q000188:drug therapy*; D012669:Seminal Vesicles; D013752:Tetracycline / Q000627:therapeutic use; D014011:Tinidazole / Q000627:therapeutic use; D014245:Trichomonas Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D014011:Tinidazole; D004917:Erythromycin; D013752:Tetracycline
Therapie der Prostato-Vesikulitis.